Science Explorer Interactive view Map
Hospital / health system · Reggio Calabria · Italy

Azienda ospedaliera "Bianchi-Melacrino-Morelli"

In research, Azienda ospedaliera "Bianchi-Melacrino-Morelli" stands highest in Medicine (#7,989 of 10,443 worldwide) and Health Sciences (#9,847 of 11,982 worldwide), 2022–2025.

ospedalerc.itROR OpenAlex
World rank, 2022–2025
#21,580
of 28,054 · #26,132 all time
Rank in Italy
#560
of 618
Research works
421
▲ 94% vs 2013–17
Citations
7k
16.5 per fractional work
Top-10% rate
15.2%
record average 16.5%
Open access
46%
world 28%

What is Azienda ospedaliera "Bianchi-Melacrino-Morelli" known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #7,989 of 10,443 14.1%74 #10839
Health SciencesDomain #9,847 of 11,982 14.1%74 #13189

Each strip is that field’s whole ranked pool, with the notch where Azienda ospedaliera "Bianchi-Melacrino-Morelli" sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.74× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 2.06× its world share, 2 worksImmunology and Micro…Neuroscience: 1.20× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.11× its world share, 2 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMathematics: 0.24× its world share, 0 worksMathematicsDentistry: 0.40× its world share, 0 worksDentistryHealth Professions: 0.15× its world share, 0 worksHealth ProfessionsMedicine: 4.23× its world share, 74 worksMedicineNursing: 0.19× its world share, 0 worksNursingVeterinary: 0.54× its world share, 0 worksVeterinaryArts and Humanities: 0.11× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.22× its world share, 0 worksEconomics, Econometr…Psychology: 0.12× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

Who are the top researchers at Azienda ospedaliera "Bianchi-Melacrino-Morelli"?

Ranked on the composite score, Bruno Martino, Caterina Stelitano and G. Gambardella lead among researchers whose main affiliation is Azienda ospedaliera "Bianchi-Melacrino-Morelli".

  1. 1 Bruno Martino Italy · #273,596 worldwide 108 citations · 24 works
  2. 2 Caterina Stelitano Italy · #509,547 worldwide 71 citations · 41 works
  3. 3 G. Gambardella Italy · #626,868 worldwide 58 citations · 15 works
  4. 4 Esther Natalie Olíva Italy · #841,602 worldwide 23 citations · 21 works
  5. 5 Pasquale Iacopino Italy · #1,063,076 worldwide 12 citations · 18 works
  6. 6 Francesco Nobile Italy · #1,106,268 worldwide 17 citations · 26 works
  7. 7 Massimo Martino Italy · #1,117,922 worldwide 30 citations · 53 works
All ranked researchers at Azienda ospedaliera "Bianchi-Melacrino-Morelli"

Which keywords describe research at Azienda ospedaliera "Bianchi-Melacrino-Morelli"?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Lymphoma, Immunotherapy, Cardiovascular Disease, Inflammation, Hematopoietic Stem Cells, Minimal Residual Disease and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors8▲ 20×10 topics
  2. Inflammation6▲ 3.3×34 topics
  3. Epidemiology6▲ 1.67×38 topics
  4. Cardiovascular Disease5▲ 5.0×22 topics
  5. Lymphoma5▲ 35×3 topics
  6. Immunotherapy5▲ 7.6×13 topics
  7. Cancer Immunotherapy4▲ 26×2 topics
  8. Hematopoietic Stem Cells4▲ 46×3 topics
  9. Minimal Residual Disease4▲ 58×2 topics
  10. Leukemia4▲ 46×2 topics
  11. Tumor Regression4▲ 36×2 topics
  12. CAR T Cells3▲ 52×1 topic
  13. Chimeric Antigen Receptor3▲ 52×1 topic
  14. Classification3▲ 8.2×5 topics
  15. Endovascular Repair3▲ 45×3 topics
  16. Mortality3▲ 6.0×7 topics
  17. Quality of Life3▲ 2.4×12 topics
  18. Chemotherapy3▲ 5.0×16 topics
  19. Risk Factors3▲ 3.1×9 topics
  20. Rituximab3▲ 21×3 topics
  21. AML3▲ 61×1 topic
  22. Acute Myeloid Leukemia3▲ 61×1 topic
  23. Echocardiography3▲ 11×6 topics
  24. Guidelines2▲ 5.7×6 topics
  25. Prognostic Scoring System2▲ 67×2 topics
  26. Surgery2▲ 7.4×6 topics
  27. Chronic Kidney Disease2▲ 11×6 topics
  28. Surgical Management2▲ 5.7×7 topics
  29. Acute Lymphoblastic Leukemia2▲ 65×1 topic
  30. Childhood Cancer2▲ 65×1 topic
  31. JAK2 Mutation2▲ 96×1 topic
  32. Myelofibrosis2▲ 96×1 topic
  33. PET Imaging2▲ 13×4 topics
  34. Revascularization2▲ 15×3 topics
  35. Mutation2▲ 11×4 topics
  36. Antiepileptic Drugs2▲ 26×2 topics
  37. Epilepsy2▲ 19×3 topics
  38. Deep Vein Thrombosis2▲ 24×2 topics
  39. Molecular Profiling2▲ 19×2 topics
  40. Proteasome Inhibitors2▲ 27×2 topics

Which research topics does Azienda ospedaliera "Bianchi-Melacrino-Morelli" publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Acute Lymphoblastic Leukemia research.

CAR-T cell therapy research: 3 fractional worksAcute Myeloid Leukemia Research: 3 fractional worksMyeloproliferative Neopl…2Myeloproliferative Neoplasms: Diagnosis and Treatment: 2 fractional worksAcute Lymphoblastic Leuk…2Acute Lymphoblastic Leukemia research: 2 fractional worksAbdominal vascular conditions and treatments: 2 fractional worksMultiple Myeloma Research and Treatments: 2 fractional worksLymphoma Diagnosis and T…2Lymphoma Diagnosis and Treatment: 2 fractional worksChronic Myeloid Leukemia Treatments: 2 fractional worksAortic aneurysm repair treatments: 1 fractional worksEpilepsy research and tr…1Epilepsy research and treatment: 1 fractional works
OncologyHematologyGeneticsPublic Health, Environmental and Occupational Health4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Acute Myeloid Leukemia Research Hematology 3 works
  3. 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  4. 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
  5. 5 Abdominal vascular conditions and treatments Surgery 2 works
  6. 6 Multiple Myeloma Research and Treatments Hematology 2 works
  7. 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 2 works
  9. 9 Aortic aneurysm repair treatments Pulmonary and Respiratory Medicine 1 works
  10. 10 Epilepsy research and treatment Psychiatry and Mental health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.5%not open54.5%

World: 28% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 19% is written across borders.

How has Azienda ospedaliera "Bianchi-Melacrino-Morelli"'s research output changed?

Output in 2018–2022 was 94% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Reggio Calabria

All research institutions in Reggio Calabria

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.